788 related articles for article (PubMed ID: 19392907)
41. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
[TBL] [Abstract][Full Text] [Related]
42. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
[TBL] [Abstract][Full Text] [Related]
43. [Buprenorphine and methadone to opiate addicts--a randomized trial].
Kristensen Ø; Espegren O; Asland R; Jakobsen E; Lie Ø; Seiler S
Tidsskr Nor Laegeforen; 2005 Jan; 125(2):148-51. PubMed ID: 15665884
[TBL] [Abstract][Full Text] [Related]
44. The prevalence and factors associated with QTc prolongation among emergency department patients.
Seftchick MW; Adler PH; Hsieh M; Wolfson AB; Chan ST; Webster BW; Frattaroli GD
Ann Emerg Med; 2009 Dec; 54(6):763-8. PubMed ID: 19419793
[TBL] [Abstract][Full Text] [Related]
45. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
Pearson EC; Woosley RL
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
[TBL] [Abstract][Full Text] [Related]
46. QTc prolongation and torsades de pointes associated with methadone therapy.
Routhier DD; Katz KD; Brooks DE
J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
[TBL] [Abstract][Full Text] [Related]
47. [Review of cases of prolonged QTC and wave burst arrhythmia in patients treated with methadone].
Laqueille X; Richa S; Kerbage H; Scart-Gres C; Berleur MP
Encephale; 2012 Feb; 38(1):58-63. PubMed ID: 22381725
[TBL] [Abstract][Full Text] [Related]
48. Comparison of costs and utilization among buprenorphine and methadone patients.
Barnett PG
Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
[TBL] [Abstract][Full Text] [Related]
49. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
[TBL] [Abstract][Full Text] [Related]
50. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
[TBL] [Abstract][Full Text] [Related]
51. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
Sullivan LE; Chawarski M; O'Connor PG; Schottenfeld RS; Fiellin DA
Drug Alcohol Depend; 2005 Jul; 79(1):113-6. PubMed ID: 15943950
[TBL] [Abstract][Full Text] [Related]
52. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities.
Golzari H; Dawson NV; Speroff T; Thomas C
Conn Med; 2007 Aug; 71(7):389-97. PubMed ID: 17879860
[TBL] [Abstract][Full Text] [Related]
53. The QTc effect of low-dose methadone for chronic pain: a prospective pilot study.
Grodofsky S; Edson E; Huang S; Speck RM; Hatchimonji J; Lacy K; Farrar JT; Ashburn MA
Pain Med; 2015 Jun; 16(6):1112-21. PubMed ID: 25644980
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
Winstock AR; Lea T; Sheridan J
Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
[TBL] [Abstract][Full Text] [Related]
55. Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.
Vallecillo G; Mojal S; Roquer A; Martinez D; Rossi P; Fonseca F; Muga R; Torrens M
Clin Infect Dis; 2013 Oct; 57(8):1189-94. PubMed ID: 23899678
[TBL] [Abstract][Full Text] [Related]
56. QTc prolongation among hospitalized patients receiving methadone.
Schmittner J; Krantz MJ
Arch Intern Med; 2006 Nov; 166(20):2289; author reply 2289-90. PubMed ID: 17101954
[No Abstract] [Full Text] [Related]
57. Prolonged QTc as a predictor of mortality in acute ischemic stroke.
Stead LG; Gilmore RM; Bellolio MF; Vaidyanathan L; Weaver AL; Decker WW; Brown RD
J Stroke Cerebrovasc Dis; 2009; 18(6):469-74. PubMed ID: 19900651
[TBL] [Abstract][Full Text] [Related]
58. Methadone-associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Walroth TA; Ott CA; Desta Z; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Mar; 41(3):238-246. PubMed ID: 33345336
[TBL] [Abstract][Full Text] [Related]
59. Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients.
Baker JR; Best AM; Pade PA; McCance-Katz EF
Ann Pharmacother; 2006 Mar; 40(3):392-6. PubMed ID: 16507617
[TBL] [Abstract][Full Text] [Related]
60. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
